Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis

被引：0
|
作者：
Clélia Monchablon
Henri Gondé
Sophie Pouplin
Rémi Varin
Olivier Vittecoq
Thierry Lequerré
机构：
[1] Rouen University Hospital,Department of Pharmacy
[2] Rouen University Hospital,Normandie Univ, UNIROUEN, U1234 Inserm, Department of Pharmacy
[3] Rouen University Hospital,Department of Rheumatology
[4] Rouen University Hospital,Normandie Univ, UNIROUEN, U1234 Inserm, Department of Rheumatology
来源：
Clinical Rheumatology | 2020年 / 39卷
关键词：
Adherence; Medication; Questionnaire; Rheumatoid arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：207 / 216
页数：9
相关论文
共 50 条
  • [21] Medication adherence to disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis at Assiut University Hospital, Egypt
    Safaa A. Mahran
    Tayser Mohamed Khedr
    Esraa Moustafa Mohammed
    Eman Mohamed Hussein El-Hakeim
    Egyptian Rheumatology and Rehabilitation, 47
  • [22] Medication adherence to disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis at Assiut University Hospital, Egypt
    Mahran, Safaa A.
    Khedr, Tayser Mohamed
    Mohammed, Esraa Moustafa
    El-Hakeim, Eman Mohamed Hussein
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2020, 47 (01)
  • [23] Pharmacogenetics of disease-modifying anti-rheumatic drugs
    Tanaka, E
    Taniguchi, A
    Urano, W
    Yamanaka, H
    Kamatani, N
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2004, 18 (02): : 233 - 247
  • [24] Disease-modifying anti-rheumatic drugs - Cyclosporin
    Chaudhuri, K
    Torley, H
    Madhok, R
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (09): : 1016 - 1021
  • [25] Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis
    Choy, Ernest H.
    RHEUMATOLOGY, 2019, 58 : 51 - 55
  • [26] Treatment Patterns of Disease-Modifying Anti-Rheumatic Drugs by Serostatus Among Patients with Rheumatoid Arthritis
    Jin, Yinzhu
    Liu, Jun
    Desai, Rishi
    Kim, Seoyoung
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3476 - 3479
  • [27] Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis
    Navarro-Millan, Iris
    Goyal, Parag
    Safford, Monika M.
    RHEUMATOLOGY, 2019, 58 (06) : 933 - 934
  • [28] DISEASE MODIFYING ANTI-RHEUMATIC DRUG ADHERENCE IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS
    Ayano, Nakayama
    Bruce, Shadbolt
    Allison, Tong
    Kathleen, Tymms
    Chandima, Perera
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 17 - 17
  • [29] Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs
    Pavelka, Karel
    Kavanaugh, Arthur F.
    Rubbert-Roth, Andrea
    Ferraccioli, Gianfranco
    RHEUMATOLOGY, 2012, 51 : V12 - V21
  • [30] Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis
    Su, Yu-Jih
    Chen, Hui-Ming
    Chan, Tien-Ming
    Cheng, Tien-Tsai
    Yu, Shan-Fu
    Chen, Jia-Feng
    Lin, Chun-Yu
    Hsu, Chung-Yuan
    RMD OPEN, 2023, 9 (03):
12345